查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1310943

寡核苷酸合成市場：副產品（設備、連接器和適配器、探針）、類型（客製化、工程）、用途、最終用戶 - COVID-19 的累積影響、俄羅斯-烏克蘭衝突、高通貨膨脹- 2023- 2030 年2020 年世界預測

Oligonucleotide Synthesis Market by Product (Equipment, Linkers & Adaptor, Probes), Type (Custom, Pre-designed), Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球寡核苷酸合成市場預計將大幅成長，預計2023年將達到102.9579億美元，年複合成長率為20.04%，預計2030年將達到3741836萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球寡核苷酸合成市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球寡核苷酸合成市場規模及預測為何？

2.在預測期內，COVID-19對全球寡核苷酸合成市場的阻礙因素和影響為何？

3. 在預測期內，全球寡核苷酸合成市場需要投資哪些產品/細分市場/應用/領域？

4.全球寡核苷酸合成市場的競爭策略為何？

5. 全球寡核苷酸合成市場的技術趨勢和法律規範是什麼？

6.全球寡核苷酸合成市場主要廠商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球寡核苷酸合成市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 人們越來越關注慢性病的傳播和藥物研發
      • 合成寡核苷酸在分子診斷和臨床應用的使用越來越多
      • 對製藥和生物技術研究的大量投資
    • 抑制因素
      • 寡核苷酸製造成本高
    • 機會
      • 寡核苷酸合成的改進與進步
      • 策略聯盟增加寡核苷酸產量
    • 任務
      • 與大規模寡核苷酸合成相關的併發症
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 寡核苷酸合成市場：副產品

  • 裝置
  • 連接子和適配器
  • 探測
  • 試劑及消耗品
  • 服務
  • 合成寡核苷酸

第7章 寡核苷酸合成市場：依類型

  • 風俗
  • 預先設計的

第8章 寡核苷酸合成市場：依用途

  • 診斷
  • 調查
  • 治療性的

第9章 寡核苷酸合成市場：依最終用戶分類

  • 學術研究所
  • 合約研究官（CRO）和首席行銷長（CMO）
  • 診斷實驗室和醫院
  • 製藥和生物技術公司

第10章 美洲寡核苷酸合成市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太寡核苷酸合成市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲寡核苷酸合成市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 投資、資金籌措
    • 獎項/獎勵/擴展

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-0A609A26A92C

The Global Oligonucleotide Synthesis Market is forecasted to grow significantly, with a projected USD 10,295.79 million in 2023 at a CAGR of 20.04% and expected to reach a staggering USD 37,418.36 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Oligonucleotide Synthesis Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Oligonucleotide Synthesis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Equipment, Linkers & Adaptor, Probes, Reagents & Consumables, Services, and Synthesized Oligonucleotides. The Equipment commanded largest market share of 19.12% in 2022, followed by Synthesized Oligonucleotides.

Based on Type, market is studied across Custom and Pre-designed. The Custom commanded largest market share of 62.34% in 2022, followed by Pre-designed.

Based on Application, market is studied across Diagnostic, Research, and Therapeutic. The Research commanded largest market share of 48.57% in 2022, followed by Diagnostic.

Based on End-User, market is studied across Academic Research Institutes, CROs & CMOs, Diagnostic Laboratories & Hospitals, and Pharmaceutical & Biotechnology Companies. The CROs & CMOs commanded largest market share of 37.25% in 2022, followed by Pharmaceutical & Biotechnology Companies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 43.72% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Oligonucleotide Synthesis Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Oligonucleotide Synthesis Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oligonucleotide Synthesis Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oligonucleotide Synthesis Market?

4. What is the competitive strategic window for opportunities in the Global Oligonucleotide Synthesis Market?

5. What are the technology trends and regulatory frameworks in the Global Oligonucleotide Synthesis Market?

6. What is the market share of the leading vendors in the Global Oligonucleotide Synthesis Market?

7. What modes and strategic moves are considered suitable for entering the Global Oligonucleotide Synthesis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Oligonucleotide Synthesis Market, by Product, 2022 vs 2030
  • 4.3. Oligonucleotide Synthesis Market, by Type, 2022 vs 2030
  • 4.4. Oligonucleotide Synthesis Market, by Application, 2022 vs 2030
  • 4.5. Oligonucleotide Synthesis Market, by End-User, 2022 vs 2030
  • 4.6. Oligonucleotide Synthesis Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and growing focus on drug discovery
      • 5.1.1.2. Rising usage of synthesized oligonucleotides in molecular diagnostics and clinical applications
      • 5.1.1.3. Significant investments in pharmaceutical and biotechnology research
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of oligonucleotides production
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements and advances in oligonucleotide synthesis
      • 5.1.3.2. Strategic alliances for increasing production of oligonucleotides
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with large scale oligonucleotide synthesis
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Oligonucleotide Synthesis Market, by Product

  • 6.1. Introduction
  • 6.2. Equipment
  • 6.3. Linkers & Adaptor
  • 6.4. Probes
  • 6.5. Reagents & Consumables
  • 6.6. Services
  • 6.7. Synthesized Oligonucleotides

7. Oligonucleotide Synthesis Market, by Type

  • 7.1. Introduction
  • 7.2. Custom
  • 7.3. Pre-designed

8. Oligonucleotide Synthesis Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Research
  • 8.4. Therapeutic

9. Oligonucleotide Synthesis Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. CROs & CMOs
  • 9.4. Diagnostic Laboratories & Hospitals
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Oligonucleotide Synthesis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Oligonucleotide Synthesis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Oligonucleotide Synthesis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. UK Partnership Set To Revolutionize Oligonucleotide Manufacture
      • 13.3.1.2. Aurisco Collaborates With Cytiva To Build First Oligo Flexfactory In China
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Codexis Unveils ECO Synthesis Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
    • 13.3.3. Investment & Funding
      • 13.3.3.1. CatSci Invests In Oligonucleotides Capability For Rare Diseases
    • 13.3.4. Award, Recognition, & Expansion
      • 13.3.4.1. GenScript Expands Peptide and Oligonucleotide Production Facility in China
      • 13.3.4.2. CordenPharma Announces Entry into Oligonucleotide Manufacturing with Two-phase Investment at CordenPharma Colorado2nd May 2023
      • 13.3.4.3. Oligo Factory Opens New State-of-the-Art Oligo Manufacturing Facility
      • 13.3.4.4. Agilent Will Double Oligonucleotide Capacity
      • 13.3.4.5. WuXi STA Opens Large-Scale Oligo and Peptide Manufacturing Facility

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 6. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. OLIGONUCLEOTIDE SYNTHESIS MARKET DYNAMICS
  • FIGURE 10. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRE-DESIGNED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CROS & CMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 192. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 193. OLIGONUCLEOTIDE SYNTHESIS MARKET LICENSE & PRICING